戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 antibody-mediated rejection (AMR), even when subclinical.
2 s infection (LTBI) raise concerns for missed subclinical active tuberculosis (TB) and acquired drug-r
3                                   Rationale: Subclinical acute kidney injury (sub-AKI) refers to pati
4 tients after kidney transplant (KT), because subclinical acute rejection (subAR), currently detectabl
5 ssion assay enabled noninvasive diagnosis of subclinical acute rejection and inflammation in the graf
6 y-one LTRs consented; 6 were excluded due to subclinical acute rejection on baseline biopsy or other
7                                          Two subclinical adverse events were identified; shared safet
8           We characterized the prevalence of subclinical AF (ie, AF detected on the Zio XT Patch with
9 based elderly population and to characterize subclinical AF and the incremental diagnostic yield of 4
10        We sought to define the prevalence of subclinical AF in a community-based elderly population a
11 ought to characterize the natural history of subclinical AF in at-risk patients from the general popu
12                            The prevalence of subclinical AF was 2.5%; the prevalence of subclinical A
13 f subclinical AF was 2.5%; the prevalence of subclinical AF was 3.3% among white men, 2.5% among whit
14 6 participants without clinical AF, 78% more subclinical AF was detected by 4 weeks versus 2 weeks of
15              In our study, the prevalence of subclinical AF was lower than previously reported and mo
16                                              Subclinical AF was mostly intermittent (75%).
17                Among those with intermittent subclinical AF, 91% had AF burden <=10% during the monit
18 pecific antibody has renewed our interest in subclinical alloreactivity.
19 l associations of E-selectin and ICAM-1 with subclinical alterations in cardiac function.
20             Early diagnosis and treatment of subclinical AMR based on the donor-specific antibody (DS
21                            Both clinical and subclinical AMR groups underwent similar treatment inclu
22 ggests that early diagnosis and treatment of subclinical AMR using DSA monitoring may improve outcome
23                                    Fifty-one subclinical AMRs (sAMRs) (41.4%) were diagnosed, of whic
24 infections are well controlled and result in subclinical and asymptomatic outcomes.IMPORTANCE Zika vi
25                   Performance for diagnosing subclinical and clinical disease in HIV-uninfected and H
26 ally infected dairy cattle were divided into subclinical and clinical infection groups, along with no
27 nd progressive enteritis that traverses both subclinical and clinical stages.
28  was decreased for clinical cows compared to subclinical and control cows.
29  conduction studies (NCS) may be used at the subclinical and early CIPN stage, to assess the extent o
30 pocampus to study the effects on spontaneous subclinical and evoked generalized seizures.
31                          Despite evidence of subclinical and paucisymptomatic Ebola Virus Disease (EV
32 ed 12% subclinical cellular rejection and 3% subclinical antibody-mediated rejection (SC-ABMR) for th
33  ABO-incompatible (ABOi) transplantation and subclinical antibody-mediated rejection in HLA-incompati
34 ansporters and metallothioneins discriminate subclinical antibody-mediated rejection in HLAi transpla
35 ocesses involved in ABOi transplantation and subclinical antibody-mediated rejection.
36 associations between [Formula: see text] and subclinical arterial disease.
37 o [Formula: see text] and progression of key subclinical arterial markers in adults: intima-media thi
38 % CI 25.9-29.2) HIV-negative individuals had subclinical atherosclerosis (p<0.0001), and these patter
39 iables to predict the presence and extent of subclinical atherosclerosis (SA) in young, asymptomatic
40                        (Progression of Early Subclinical Atherosclerosis [PESA]; NCT01410318).
41 of CD69 remained an independent predictor of subclinical atherosclerosis after adjustment for traditi
42 r at younger ages, suggesting early onset of subclinical atherosclerosis among young adults.
43 osis) with extensive (n=128) or focal (n=55) subclinical atherosclerosis and without disease (n=122).
44               Moreover, plasma biomarkers of subclinical atherosclerosis are lacking.
45 udies linking objectively measured sleep and subclinical atherosclerosis assessed in multiple vascula
46 om the EISNER trial (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Resea
47 ticipants of the PESA study with evidence of subclinical atherosclerosis displayed a significant CD69
48 urs of sleep), traditional risk factors, and subclinical atherosclerosis extent were prospectively as
49 d (>2 plaques) or incipient (0 to 2 plaques) subclinical atherosclerosis in 2 independent clinical co
50 ors detected short-term progression of early subclinical atherosclerosis in a substantial proportion
51 ly increased in individuals with generalized subclinical atherosclerosis in both PESA and NEFRONA coh
52 ell-documented increase in the prevalence of subclinical atherosclerosis in patients with steatosis,
53    Data from a cohort of the PESA study with subclinical atherosclerosis indicate that CD69 expressio
54 ts; however, progression of multiterritorial subclinical atherosclerosis is incompletely understood.
55         In contrast, the influence of ART on subclinical atherosclerosis is not clear.
56  practice guidelines recommend assessment of subclinical atherosclerosis using imaging techniques in
57                                              Subclinical atherosclerosis was defined as carotid arter
58 ter stratifying by age, higher prevalence of subclinical atherosclerosis was observed in HIV-positive
59 dy included 3,514 PESA (Progression of Early Subclinical Atherosclerosis) study participants (45.7 +/
60 rticipants in the PESA (Progression of Early Subclinical Atherosclerosis) study.
61 e enrolled in the PESA (Progression of Early Subclinical Atherosclerosis) study.
62 cification in the PESA (Progression of Early Subclinical Atherosclerosis) study.
63 ants of the PESA study (Progression of Early Subclinical Atherosclerosis) with extensive (n=128) or f
64                EN-PESA (Progression of Early Subclinical Atherosclerosis) yielded a c-statistic of 0.
65  congenital heart disease, rhythm disorders, subclinical atherosclerosis, coronary heart disease, hea
66             HIV infection is associated with subclinical atherosclerosis, independent of classic risk
67 education level is associated with increased subclinical atherosclerosis, mainly mediated by the high
68 ng value as a novel circulating biomarker of subclinical atherosclerosis.
69 ions of HIV-positive serostatus and FRS with subclinical atherosclerosis.
70 valent in middle-aged individuals with known subclinical atherosclerosis.
71 he clinical relevance of CVs associated with subclinical atherosclerosis.
72 ng the association between HIV infection and subclinical atherosclerosis.
73 ic of 0.88 for the prediction of generalized subclinical atherosclerosis.
74 clinical cohorts (PESA [Progression of Early Subclinical Atherosclerosis] [n = 360] and NEFRONA [Nati
75                            The prevalence of subclinical atrial fibrillation (AF) in the elderly gene
76 heart rhythm monitoring technologies emerge, subclinical atrial fibrillation (AF) signifies a future
77 ce, clinical significance, and management of subclinical atrial fibrillation and identifies current g
78 ve value of prolonged cardiac monitoring for subclinical atrial fibrillation detection through smartp
79                           Thus, detection of subclinical atrial fibrillation may offer an opportunity
80 phenotype in adulthood, thereby reflecting a subclinical barrier defect seen in humans.
81             (18)F-fluoride PET-CT identifies subclinical bioprosthetic valve degeneration, providing
82                                        These subclinical brain changes could be the underlying mechan
83 ection, with the presence and progression of subclinical brain disease in the general population.
84 ariation was associated with a wide range of subclinical brain structural changes, including MRI mark
85 W) were used to explore associations between subclinical CAD and cumulative exposure to the 10 most f
86                                The following subclinical CAD endpoints were analyzed separately: CAC
87  ART agents and the prevalence and extent of subclinical CAD.
88  associated with lower levels of markers for subclinical cardiac damage and strain in adults without
89 ociations between E-selectin and ICAM-1 with subclinical cardiac dysfunction are unclear.
90  of echocardiographic parameters to identify subclinical cardiac dysfunction in the absence of overt
91 cent evidence suggests that BDNF has adverse subclinical cardiac remodeling in participants with card
92 model assessment of insulin resistance) with subclinical cardiovascular disease (CVD) among blacks.
93 cular health (CVH) is associated with future subclinical cardiovascular disease (CVD), but data are l
94 of clinical applications to the detection of subclinical cardiovascular disease (CVD).
95 arkers are screening tools that may identify subclinical cardiovascular disease and those at elevated
96 g into routine clinical practice to identify subclinical cardiovascular dysfunction, have rendered th
97                                   In 2004, a subclinical case of variant Creutzfeldt-Jakob disease in
98                                  We used 12% subclinical cellular rejection and 3% subclinical antibo
99 dition, CKD is also strongly associated with subclinical cerebrovascular abnormalities, vascular cogn
100 OCT angiography revealed numerous additional subclinical choroidal lesions and were used to track dis
101                              In PMR, whether subclinical chronic inflammation can lead to long-term d
102                                              Subclinical CMV and EBV shedding could contribute to the
103            Valacyclovir treatment suppressed subclinical CMV reactivation and reduced CD4+CD28null T-
104                         We hypothesized that subclinical CMV reactivation drives CD4+CD28null T-cell
105    Minimal hepatic encephalopathy (MHE) is a subclinical cognitive impairment frequently observable i
106 ves and becomes more widely accessible, more subclinical congenital malformations are being detected.
107                                              Subclinical corneal edema in FECD can be detected by Sch
108 -positive (TCR(+)) T cells were observed for subclinical cows compared to clinical cows.
109 n-specific immune responses, the profile for subclinical cows was one of a dominant proinflammatory r
110 ory cytokine genes were upregulated only for subclinical cows, whereas increased IL-10 and IL-17 gene
111 despite LPs to identify and treat those with subclinical cryptococcal meningitis and preemptive fluco
112  with higher odds of CAC, abnormal cIMT, and subclinical CVD (all P <0.001).
113 fied in early adulthood were associated with subclinical CVD development over 20 years, specifying kn
114 model assessment of insulin resistance) with subclinical CVD measures were adjusted for traditional C
115 thelial dysfunction (ED), an early marker of subclinical CVD risk, in youth living with perinatally a
116                                              Subclinical CVD was defined as >=1 of the following: any
117                   This case series describes subclinical development of severe acute respiratory synd
118                                Assessment of subclinical disease and physiological profiling of these
119 ardiac magnetic resonance imaging identified subclinical disease features such as diastolic dysfuncti
120 hanism(s) for the shift from an asymptomatic subclinical disease state to advanced clinical disease i
121  that modulate initiation and progression of subclinical disease to inform efforts in development of
122 s stages of CAD, from the detection of early subclinical disease to the assessment of acute chest pai
123 oad spectrum of severity, extending from the subclinical domain to clinical diagnosis.
124 sociation to assess the relationship between subclinical donor AKI (elevated biomarkers without creat
125 se model of chemically-induced cSCC, where a subclinical dose of 7,12-dimethylbenz[a]anthracene cause
126                   The clinical importance of subclinical, early T cell-mediated rejection (Banff TCMR
127 nite edema (based on slit-lamp examination), subclinical edema (based on tomographic features without
128 15), in >=81% of FECD corneas suspicious for subclinical edema (n = 16), in <=42% of FECD corneas dee
129 obvious visible edema), being suspicious for subclinical edema (possible corneal thickening without o
130  features after EK confirmed the presence of subclinical edema preoperatively.
131                       Corneas suspicious for subclinical edema that subsequently underwent EK (n = 9)
132                                Patients with subclinical EDS and brain injury may experience a slower
133 velopment; innovative methods to account for subclinical effects are needed.
134 zing the immune, environmental and molecular subclinical events preceding PsA onset.
135                                   Subsequent subclinical exposures to the allergen induced IgE(+) ger
136 tinocyte carcinoma (KC) is the unpredictable subclinical extension.
137 evident cases of prosopagnosia could predict subclinical facial agnosia in an independent lesion coho
138 nt predictors of prosopagnosia and predicted subclinical facial agnosia in an independent lesion coho
139 h specific histopathological phenotype(s) of subclinical graft injury.
140 ease (IBD) and the even higher occurrence of subclinical gut inflammation in patients with SpA.
141 ge (Stage 3), or right ventricular damage or subclinical heart failure (Stage 4).
142                     Our results suggest that subclinical HEV infection exists among LT patients in th
143  associations of endothelial activation with subclinical HF with preserved ejection fraction.
144                                  We examined subclinical histologic and functional changes in kidney
145    In endemic areas, screening for latent or subclinical histoplasmosis should be implemented before
146 ed women during ART for 28 days to establish subclinical HSV DNA shedding rates and detection of HIV
147                                     Frequent subclinical HSV DNA shedding was associated with increas
148 was observed in two women with less frequent subclinical HSV DNA shedding.
149                                              Subclinical HSV shedding in HIV/HSV-coinfected women dur
150 RM recapitulates many of the key features of subclinical HSV-2 infection in women but seems to be mor
151  host-HSV-2 interactions, an animal model of subclinical HSV-2 infection is needed.
152 e interval = - 0.17 to 0.76, I(2) = 15.6) or subclinical hyperthyroidism (- 0.10, 95% confidence inte
153                                    Overt and subclinical hyperthyroidism affected 0.26% and 0.78%, re
154  1342 had subclinical hypothyroidism and 671 subclinical hyperthyroidism.
155 a (IPD) analysis comparing participants with subclinical hypo- or hyperthyroidism versus euthyroidism
156 res did not differ between participants with subclinical hypothyroidism (mean difference = 0.29, 95%
157                                              Subclinical hypothyroidism (SCH) is a common endocrine d
158 prove hypothyroid symptoms among adults with subclinical hypothyroidism (SCH).
159 were female, 21,025 were euthyroid, 1342 had subclinical hypothyroidism and 671 subclinical hyperthyr
160 is preliminary study involving patients with subclinical hypothyroidism and acute myocardial infarcti
161 eatment might be indicated for patients with subclinical hypothyroidism and serum thyrotropin levels
162 r for young and middle-aged individuals with subclinical hypothyroidism and symptoms consistent with
163 thyroidism should be treated, but those with subclinical hypothyroidism do not always benefit from tr
164 ic type, both in normal thyroid group and in subclinical hypothyroidism group (40.4% and 46.7%, respe
165 outine use of levothyroxine for treatment of subclinical hypothyroidism in adults aged 80 years and o
166 on that subclinical thyroid dysfunction, and subclinical hypothyroidism in particular, is associated
167   These findings do not support treatment of subclinical hypothyroidism in patients with acute myocar
168                                              Subclinical hypothyroidism in patients with acute myocar
169                                              Subclinical hypothyroidism is most often caused by autoi
170                                              Subclinical hypothyroidism may be associated with an inc
171       In addition, middle-aged patients with subclinical hypothyroidism may have cognitive impairment
172 f prescribing levothyroxine in patients with subclinical hypothyroidism to reduce the risk of develop
173 ot on treatment, the prevalence of overt and subclinical hypothyroidism was 0.82% and 6.06%, respecti
174 pothyroidism) or within the reference range (subclinical hypothyroidism).
175                                              Subclinical hypothyroidism, defined as an elevated serum
176                                           In subclinical hypothyroidism, the presence of depressive s
177 nvolving adults aged 80 years and older with subclinical hypothyroidism, treatment with levothyroxine
178 dwelling adults aged 80 years and older with subclinical hypothyroidism.
179 efits in adults aged 80 years and older with subclinical hypothyroidism.
180         Purpose To investigate the extent of subclinical imaging changes in terms of fibrosis and inf
181 provide early surveillance for the potential subclinical impact of cardiovascular and metabolic risk
182 ng they offer improved sensitivity to detect subclinical incipient disease.
183 wever, most infants with cCMV infection have subclinical infection and go undiagnosed.
184                                              Subclinical infection associated with orthopedic devices
185 Our results demonstrate a high prevalence of subclinical infection in household contacts of pertussis
186             Functional analysis in vivo in a subclinical infection model also indicated that Lrrk2 su
187 nges in peri-implant bone, characteristic of subclinical infection.
188 V-rectal inoculation results in viremia with subclinical infection.
189 us infections on the incidence of subsequent subclinical infections and diarrhea in children under 2
190 gns, indicating that this species can harbor subclinical infections and potentially serve as disease
191  genotypes in the community, causing mild or subclinical infections in children.
192 s circulate in the community causing mild or subclinical infections in children.
193 s circulate in the community causing mild or subclinical infections in children.Parechovirus can caus
194             HEV RNA was detected, indicating subclinical infections in patients with or without serop
195 ion, particularly if the transmissibility of subclinical infections is low.
196 tential mechanisms behind these repeated and subclinical infections, such as poor induction of immuno
197  before symptom onset, and the proportion of subclinical infections.
198 ed to more attenuated strains, which produce subclinical infections.
199 s the remaining patients were judged to have subclinical infections.
200 arly identification of CS refractoriness and subclinical inflammation in patients with VKH disease.
201                                              Subclinical inflammation is associated with an increased
202                                              Subclinical injury in transplanted kidneys without AKI w
203 pen ADAMTS13 conformation is a biomarker for subclinical iTTP and could become an important tool in T
204 a novel biomarker that can be used to detect subclinical iTTP in patients in remission.
205 haracteristics in patients with keratoconus, subclinical keratoconus and normal corneas.
206 dditionally to propose a diagnostic model of subclinical keratoconus based in binary logistic regress
207 ferential diagnosis between normal cases and subclinical keratoconus depends on the minimum corneal t
208                             Repeatability in subclinical keratoconus did not differ significantly fro
209 utyric acid, BHB) is used as an indicator of subclinical ketosis in cows.
210 ns, genes and pathways potentially affecting subclinical ketosis in North American Holstein dairy cat
211 dicted milk BHB concentrations (indicator of subclinical ketosis) in the first lactation (SCK1) and s
212                                              Subclinical leaflet thickening and reduced leaflet motio
213                                              Subclinical leaflet thrombosis has been reported after b
214                                              Subclinical leaflet thrombosis was more frequent in tran
215                                              Subclinical leaflet thrombosis, characterized by hypoatt
216 he one hand, concerns about ischemic stroke, subclinical leaflet thrombosis, valve thrombosis, and lo
217 trial fibrillation and potentially attenuate subclinical leaflet thrombosis.
218 an antiplatelet-based strategy in preventing subclinical leaflet-motion abnormalities.
219  We hypothesized that HEV might persist at a subclinical level and might pose clinical risks in the p
220 symptomatic infection may be associated with subclinical lung abnormalities, as detected by computed
221 erity was associated with LV hypertrophy and subclinical markers of LV diastolic dysfunction.
222 tion was identified between SDB severity and subclinical markers of LV systolic function.
223 itis and can result in both clinical (CM) or subclinical mastitis (SCM).
224                                              Subclinical mastitis by Staphylococcus aureus (SAU) and
225 n (CrAg) titers in blood are associated with subclinical meningitis and mortality in CrAg-positive in
226 to the Belin/Ambrosio total deviation value: subclinical, mild, and moderate.
227 ed a double-layer sign in 24 of 33 eyes with subclinical MNV and did not detect a double-layer sign i
228 ed a double-layer sign in 29 of 33 eyes with subclinical MNV and did not detect a double-layer sign i
229         A set of test scans with and without subclinical MNV was compiled to assess the ability of tr
230 ntermediate AMD, which included 20 eyes with subclinical MNV, and 36 eyes with late AMD, which includ
231 s with late AMD, which included 13 eyes with subclinical MNV.
232 asured by microperimetry in the detection of subclinical multiple sclerosis-related retinal damage an
233 ndently associated with an increased risk of subclinical multiterritory atherosclerosis.
234  the association of cancer survivorship with subclinical myocardial damage, as assessed by elevated h
235  the association of cancer survivorship with subclinical myocardial damage, as assessed by elevated h
236         Widely available measures of lipids, subclinical myocardial injury, myocardial strain, and va
237 hanges in myocardial deformation, suggesting subclinical myocardial injury.
238 lay a SIRE sign are at higher risk of having subclinical NE-MNV.
239                                              Subclinical nephrosclerosis, larger cortical nephron siz
240 imal familial risk for developing MS, showed subclinical neuroinflammation (SCNI) with small MRI lesi
241 as exudation does not occur, it appears that subclinical nonexudative MNV is not responsible for the
242                            The prevalence of subclinical nonexudative neovascular AMD in the fellow e
243 uture cardiovascular events in patients with subclinical, nonobstructive coronary artery disease.
244  this isotonic skin Na(+) excess, reflecting subclinical oedema, occurs in hypertensive patients and
245 iopsies over 2 years, identifying those with subclinical or borderline acute cellular rejection (ACR)
246 of incident disease, as a screening test for subclinical or clinical tuberculosis, and for monitoring
247  individuals for investigation of incipient, subclinical, or active TB disease for appropriate treatm
248 mography (microCT) imaging in a rat model of subclinical orthopedic device-related infection caused b
249 ta for the detection and characterization of subclinical orthopedic infections, whilst also reducing
250                     Of 221 participants with subclinical P. falciparum infections who participated in
251 nic clearance and enabling several months of subclinical parasite persistence.
252 eatment of an entire population to clear the subclinical parasite reservoir, is a strategy to acceler
253                            Understanding the subclinical pathway to cellular engraftment following ha
254                       Also, adolescents with subclinical periodontitis had statistically significantl
255      The main finding of this study was that subclinical periodontitis in adolescents was statistical
256                         This proinflammatory subclinical periodontitis stage, which represents stage
257 , and dental plaque than adolescents without subclinical periodontitis.
258 nsistent with gestation-induced worsening of subclinical pre-existing chronic cardiovascular dysfunct
259                     nePVAC may represent the subclinical pre-exudative stage of ePVAC, notable for an
260 focused on a subgroup of twins with signs of subclinical, prodromal MS in the clinically healthy cotw
261 y, and developmental trajectories of diverse subclinical psychopathological symptoms that pose a risk
262             These data indicate the onset of subclinical pulmonary perfusion abnormalities that could
263                             The detection of subclinical RD or early termination of outer retinal lay
264 9%, 95% CI, 0.2-50.6) developed OCT-detected subclinical recurrences within 3 months, treated by 1 la
265 ent in 374 (18.2% prevalence) from acute and subclinical rejection (67.4%); interstitial fibrosis and
266                                              Subclinical rejection (SCR) screening in kidney transpla
267 ral, and more specifically in the context of subclinical rejection following KT.
268           The identification of DSA positive subclinical rejection might help to define patients with
269 was no clinical rejection in the first year; subclinical rejection was detected by protocol biopsy in
270 ts following kidney transplantation (KT), as subclinical rejection, currently detectable only with in
271 ts with DGF had a higher 1-year incidence of subclinical rejection, which were mostly antibody-mediat
272                                              Subclinical retinal detachment (RD) was also noted in 1
273            We conclude that the animal had a subclinical SARS-CoV-2 infection concomitant to an unrel
274 lnesses, and annual blood testing identifies subclinical seroconversions.
275              We show that NLRX1 inhibits the subclinical stages of microglial activation and prevents
276 nd electroencephalography revealed her focal subclinical status.
277 uisition of both HIV and HSV-2 infections is subclinical, study of the initial molecular interactions
278 stent with previous studies that identified "subclinical" subjects, presenting normal laryngeal funct
279   We investigated the effect of clinical and subclinical T cell-mediated rejection (C-TCMR and SC-TCM
280                                              Subclinical T cell-mediated rejection (subTCMR) is commo
281 l" biopsies of normally functioning grafts: "subclinical" TCMR.
282  We aimed to examine the association between subclinical thyroid dysfunction and depressive symptoms
283 a are conflicting on the association between subclinical thyroid dysfunction and depressive symptoms.
284 d no clinically relevant association between subclinical thyroid dysfunction at baseline and depressi
285 in contrast with the traditional notion that subclinical thyroid dysfunction, and subclinical hypothy
286                                              Subclinical thyroid dysfunction, defined as thyroid-stim
287 e different stages of infection and disease (subclinical to clinical).
288 ld mammals, and humans, where they can cause subclinical to fatal disease.
289   Owner-reported quality of life ranged from subclinical to occasional exertional syncope.
290  there is a greater risk of progression from subclinical to overt hypothyroidism.
291                                              Subclinical traits that mirror the core features of ASD,
292 TA) as a primary diagnostic tool to evaluate subclinical (treatment-naive), nonexudative, neovascular
293                               Although rare, subclinical tuberculosis disease can be missed during ev
294            The identified high prevalence of subclinical tubular impairment also highlights the impor
295 n structural OCT B-scans was associated with subclinical type 1 MNV and can be used to identify these
296 layer sign was used as a predictive sign for subclinical type 1 MNV.
297 ction may be involved in the pathogenesis of subclinical vascular disease in this population.
298 ve and efficient method to identify signs of subclinical visual dysfunction that correspond with earl
299 study, cryptic CLas infections that remained subclinical visually were detected within 2 wk postinfec
300               Many infections quickly become subclinical, with episodes of spontaneous virus reactiva

 
Page Top